BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36558094)

  • 1. A Green Blue LED-Driven Two-Liquid-Phase One-Pot Procedure for the Synthesis of Estrogen-Related Quinol Prodrugs.
    De Marchi E; Botta L; Bizzarri BM; Saladino R
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical one-pot conversion of 17beta-estradiol to 10beta-hydroxy- (p-quinol) and 10beta-chloro-17beta-hydroxyestra-1,4-dien-3-one.
    Lista L; Manini P; Napolitano A; Pezzella A; d'Ischia M
    Steroids; 2006 Aug; 71(8):670-3. PubMed ID: 16730767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy.
    Prokai-Tatrai K; Nguyen V; Prokai L
    ACS Chem Neurosci; 2018 Nov; 9(11):2528-2533. PubMed ID: 29843514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prodrug Approach for Central Nervous System-Selective Estrogen Therapy.
    Prokai-Tatrai K; Prokai L
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress.
    Rivera-Portalatin NM; Vera-Serrano JL; Prokai-Tatrai K; Prokai L
    J Steroid Biochem Mol Biol; 2007; 105(1-5):71-5. PubMed ID: 17582759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.
    Prokai L; Nguyen V; Szarka S; Garg P; Sabnis G; Bimonte-Nelson HA; McLaughlin KJ; Talboom JS; Conrad CD; Shughrue PJ; Gould TD; Brodie A; Merchenthaler I; Koulen P; Prokai-Tatrai K
    Sci Transl Med; 2015 Jul; 7(297):297ra113. PubMed ID: 26203081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection.
    Prokai L; Prokai-Tatrai K; Perjesi P; Zharikova AD; Perez EJ; Liu R; Simpkins JW
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11741-6. PubMed ID: 14504383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the periphery.
    Merchenthaler I; Lane M; Sabnis G; Brodie A; Nguyen V; Prokai L; Prokai-Tatrai K
    Sci Rep; 2016 Aug; 6():30721. PubMed ID: 27477453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retina-Targeted Delivery of 17β-Estradiol by the Topically Applied DHED Prodrug.
    Prokai-Tatrai K; Nguyen V; De La Cruz DL; Guerra R; Zaman K; Rahlouni F; Prokai L
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32429388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Prokai L; Ottinger MA
    Horm Behav; 2016 Jul; 83():39-44. PubMed ID: 27210479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.
    Yan W; Wu J; Song B; Luo Q; Xu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):879-886. PubMed ID: 30879099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with brain specific estrogen prodrug ameliorates cognitive effects of surgical menopause in mice.
    Salinero AE; Abi-Ghanem C; Venkataganesh H; Sura A; Smith RM; Thrasher CA; Kelly RD; Hatcher KM; NyBlom V; Shamlian V; Kyaw NR; Belanger KM; Gannon OJ; Stephens SBZ; Zuloaga DG; Zuloaga KL
    Horm Behav; 2024 Jun; 164():105594. PubMed ID: 38917776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-Selective Estrogen Therapy Prevents Androgen Deprivation-Associated Hot Flushes in a Rat Model.
    Merchenthaler I; Lane M; Stennett C; Zhan M; Nguyen V; Prokai-Tatrai K; Prokai L
    Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32531919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10β-Hydroxyestra-1,4-diene-3,17-dione as potential antiproliferative agent: in vitro biological evaluation and in silico studies.
    Canário C; Matias M; Brito V; Cruz-Vicente P; Soeiro P; Santos AO; Falcão A; Silvestre S; Alves G
    Nat Prod Res; 2022 Dec; 36(24):6459-6463. PubMed ID: 35167416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Ottinger MA; Prokai L
    Horm Behav; 2018 Feb; 98():16-21. PubMed ID: 29183688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinol-based metabolic cycle for estrogens in rat liver microsomes.
    Prokai L; Prokai-Tatrai K; Perjesi P; Zharikova AD; Simpkins JW
    Drug Metab Dispos; 2003 Jun; 31(6):701-4. PubMed ID: 12756200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Specific Estrogen Ameliorates Cognitive Effects of Surgical Menopause in Mice.
    Salinero AE; Abi-Ghanem C; Venkataganesh H; Sura A; Smith RM; Thrasher CA; Kelly RD; Hatcher KM; NyBlom V; Shamlian V; Kyaw NR; Belanger KM; Gannon OJ; Stephens SBZ; Zuloaga DG; Zuloaga KL
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
    Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen sulfamates: a new approach to oral estrogen therapy.
    Elger W; Barth A; Hedden A; Reddersen G; Ritter P; Schneider B; Züchner J; Krahl E; Müller K; Oettel M; Schwarz S
    Reprod Fertil Dev; 2001; 13(4):297-305. PubMed ID: 11800168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.